Although PTEN was first defined as a tumor suppressor [24], emerging evidence suggests that PTEN may also function as a negative regulator of the phosphatidylinositol-3-kinase (PI3K)/AKT pathway, which plays a critical role in glucose metabolism regulation [25]. The gene discussed is AKT1; the disease is neoplasm.